Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Aug 14, 2024

SELL
$0.05 - $1.82 $5 - $191
-105 Closed
0 $0
Q1 2022

Aug 14, 2024

BUY
$4.01 - $10.42 $421 - $1,094
105 New
105 $505,000
Q2 2021

Aug 30, 2024

BUY
$11.32 - $14.45 $1,188 - $1,517
105 New
105 $1.52 Million
Q1 2021

Aug 30, 2024

BUY
$12.07 - $29.9 $1,267 - $3,139
105 New
105 $1.44 Million

Others Institutions Holding SQZ

About SQZ Biotechnologies Co


  • Ticker SQZ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 29,248,600
  • Market Cap $1.46M
  • Description
  • SQZ Biotechnologies Company, a clinical-stage biotechnology company, develops cell therapies for patients with cancer, autoimmune, infectious diseases, and other serious conditions. Its lead product candidate is SQZ-PBMC-HPV, from its SQZ Antigen Presenting Cells platform, which is in a Phase I clinical trial as a monotherapy and in combination ...
More about SQZ
Track This Portfolio

Track Federation Des Caisses Desjardins Du Quebec Portfolio

Follow Federation Des Caisses Desjardins Du Quebec and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Federation Des Caisses Desjardins Du Quebec, based on Form 13F filings with the SEC.

News

Stay updated on Federation Des Caisses Desjardins Du Quebec with notifications on news.